Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The BCI 602 BONEBRIDGE Post-Market Clinical Follow-up Study

NCT04427033 is registered in ClinicalTrials.gov with MED-EL Elektromedizinische Geräte GesmbH as lead sponsor.

NCT NCT04427033
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04427033 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The BCI 602 BONEBRIDGE Post-Market Clinical Follow-up Study
Lead sponsor
MED-EL Elektromedizinische Geräte GesmbH
Phase
Observational
Overall status
Completed
Start date
December 6, 2019
Completion date
January 18, 2024
Enrollment
52 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

hearing loss, hearing loss, bilateral, hearing loss, conductive, hearing loss, mixed, hearing loss, sensorineural, hearing loss, unilateral